Physician profile
Jonathan Brough
NPI 1447203823
$2,951.16
in general payments reported to CMS, 2019-2025
36 companies · $498 in 2025
The $498 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $104 · 2021: $337 · 2022: $739 · 2023: $518 · 2024: $470 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,473 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.70 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $595.69 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $363.83 | 2023-2025 | Myfembree |
| Pfizer INC. | $328.98 | 2019-2025 | |
| Astellas Pharma US INC | $167.41 | 2022-2024 | Veozah |
| Sage Therapeutics, LLC | $146.66 | 2021-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $144.57 | 2021-2025 | |
| Myovant Sciences INC. | $135.09 | 2022 | |
| Organon LLC | $127.31 | 2021-2025 | Nexplanon |
| Shield Therapeutics INC | $102.86 | 2024-2025 | |
| Daiichi Sankyo INC. | $101.91 | 2019-2022 | |
| Therapeuticsmd, INC. | $67.87 | 2019-2020 | |
| Coopersurgical, INC. | $58.81 | 2022-2025 | Fisherbrand Disposable Liquid Infant Heel Warmer, Ally II Ups |
| Millicent US INC | $58.13 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Hologic Sales and Service, LLC | $42.74 | 2022-2023 | Myosure Tissue Removal Device |
| Agile Therapeutics, INC. | $40.37 | 2022-2023 | Twirla |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $37.32 | 2019 | |
| Avanos Medical | $34.45 | 2021 | |
| Avion Pharmaceuticals | $34.44 | 2022-2023 | Balcoltra |
| Exeltis, USA INC. | $33.11 | 2025 | Slynd |
| Duchesnay USA Incorporated | $31.24 | 2019 | |
| Lilly USA, LLC | $24.92 | 2022 | |
| Innovation Technologies INC | $24.59 | 2025 | Irrisept |
| Biom'Up France Sas | $24.13 | 2021 | |
| Ethicon US, LLC | $23.38 | 2025 | Ethicon, Stratafix |
| Davol INC. | $21.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.86 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.87 | 2025 | Qelbree |
| Lupin INC. | $18.60 | 2021 | |
| Medtronic, INC. | $17.85 | 2025 | Ligasure |
| Pacira Pharmaceuticals Incorporated | $17.46 | 2020 | |
| Teleflex LLC | $16.42 | 2025 | Quikclot |
| Kedrion Biopharma INC. | $15.91 | 2019 | |
| Integra Lifesciences Corporation | $15.66 | 2024 | Biodrestore, Medihoney, Biodfactor |
| Becton, Dickinson and Company | $15.33 | 2022 | |
| Convatec INC. | $11.84 | 2022 | |
| Minerva Surgical, INC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Brough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.